The study aims to determine the feasibility and tolerability of single-fraction stereotactic ablative body radiation therapy (SABR) to treat primary or metastatic carcinoma of the lung, liver, adrenal gland, abdominal/pelvic lymph node, pancreas, and kidney. Read more . . .
The use of MRI-guided radiation instead of the standard CT-guided technique is being evaluated in a single-arm prospective study led by Michael Chuong, MD, radiation oncologist and medical director of proton therapy and MR-guided therapy at Miami Cancer Institute.